Tatiana M Prowell
7PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 11, 2025
Management of Cancer During Pregnancy: ASCO Guideline.Alison W Loren, Christina Lacchetti, Frédéric Amant
|Aug 11, 2025
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.Jennifer J Gao, Tatiana M Prowell, Haley Gittleman
|Jul 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.Jennifer K Litton, Meredith M Regan, Lajos Pusztai
|Oct 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.Shaily Arora, Preeti Narayan, Christy L Osgood
|Oct 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.Shaily Arora, Preeti Narayan, Gwynn Ison
|Jul 23, 2021
Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.Jeremy Mason, Yutao Gong, Laleh Amiri-Kordestani
Pageof 2
Frequent Collaborators
5 joint publications
Jennifer J Gao
3 joint publications
Laleh Amiri-Kordestani
2 joint publications
Shenghui Tang
2 joint publications
Suparna Wedam
2 joint publications
Melanie Royce
2 joint publications
Amna Ibrahim
1 joint publications
Laura L Fernandes
1 joint publications
Emily Li
1 joint publications
Kirsten B Goldberg
1 joint publications
Jeremy Mason
